Your session is about to expire
← Back to Search
CHF 1535 pMDI for Asthma (FORCE2 Trial)
FORCE2 Trial Summary
This triallooks at how two drugs compare in helping people with asthma on high-dose steroids.
FORCE2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.FORCE2 Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of severe asthma that has required hospitalization in the intensive care unit, which could put you at high risk if you participate in the study.You have had a severe asthma attack that required hospitalization, emergency room visit, or treatment with strong medication in the past 4 weeks.You have been diagnosed with asthma for at least one year and it started before you turned 40.You have been diagnosed with conditions like cystic fibrosis, bronchiectasis, COPD, or other serious lung diseases that could affect the study assessments.You are currently taking certain medications called monoamine oxidase inhibitors (MAOIs) or tricyclic antidepressants.You have used alcohol or drugs excessively in the past year.
- Group 1: CHF 1535 pMDI
- Group 2: CHF 718 pMDI
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the trial accept elderly participants over 80 years of age?
"This trial is accepting patients from the ages of 18 to 75. There are 117 studies for minors and 193 trials designed specifically with elderly persons in mind."
Has the FDA given clearance for CHF 1535 pMDI?
"Through rigorous Phase 3 trials, our team at Power has ascertained that CHF 1535 pMDI is a safe intervention for patients. Thus, it obtained a score of 3 on the safety scale from 1 to 3."
Are the criteria necessary for enrollment in this research project met by me?
"This research trial is actively enrolling up to 580 participants, aged between 18 and 75 with a diagnosis of asthma."
How many sites are responsible for overseeing this clinical trial?
"At present, this clinical trial is recruiting from a total of 96 sites. Some of the cities in which these centres are located include Chandler, Encinitas and Huntington Beach; other locations can be found around the country. Choosing to register for participation at your closest site will help reduce travelling commitments."
Does this clinical trial presently accept new participants?
"Affirmative. Clinicaltrials.gov affirms that this experiment, which was initially posted on October 5th 2022, is currently searching for participants. In total 580 patients are needed to be recruited from 96 distinct medical sites."
What is the current enrollment number of this medical research?
"This study requires 580 eligible participants, who can conveniently enrol from Chiesi Clinical Trial Site 840895 in Chandler, Arizona or at the Chiesi Clinical Trial Site 840856 location in Encinitas, California."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger